课题基金 / 基金详情

Mechanisms and consequences of antigen-dependent T cell homing for adoptive immunotherapies

Mechanisms and consequences of antigen-dependent T cell homing for adoptive immunotherapies
过继免疫疗法中抗原依赖性 T 细胞归巢的机制和后果
批准号:
10654215
负责人:
Thomas David Manes
金额:
$41.88万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
未结题
起止时间:
2023-08-15 至 2027-07-31

项目摘要

项目成果

Thomas David Manes的其他基金

相似基金

相关文献

中文摘要
翻译
项目总结/文摘
英文摘要
Project Summary/Abstract Adoptive cell therapy (ACT) with activated and expanded T or CAR T cells may be used to treat infections or tumors and ACT with T or CAR T regulatory cells are in clinical trials to control autoimmunity and allograft rejection. Many but not all patients benefit. The success of ACT depends upon T cell homing to relevant tissue sites. Normal circulating T effector memory or T regulatory cells can enter a tissue in response to their cognate antigen being displayed on the surface of the local microvascular ECs in a process triggered by TCR and modulated by costimulation. We hypothesize that antigen presentation by human endothelial cells (ECs) will recruit adoptively transferred in vitro expanded T or CAR T effector and regulatory cells to specific peripheral tissue sites in a process modulated by specific EC co-stimulators. In specific aim 1, we will test this hypothesis in vitro in models we have developed using endothelial cell monolayers in flow chambers to model in vivo conditions. We will expand our in vitro assys to include an examination of the effects that TCR- induced transendothelial migration (TEM) has on the T cells at the single cell level. In the case of CAR T cells, we will determine the most important costimulator receptor molecule motifs to be incorporated into the CAR for optimal TEM. We will also determine if human ECs have the capacity to cross-present or be “cross-dressed” by antigens allowing EC presentation of antigen to influence cancer immunotherapy. Finally, we will use a model we developed for studying adoptively transferred human T cell responses to synthestic microvessels assembled from human ECs, allowing genetic manipulation of the signals human ECs can provide. In aim 2 we will conduct similar experiments using T and CAR T regulatory cells. Successful completion of these aims will provide important information for extending the range of patients who may benefit from ACT.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Human B cell infiltration into allografts: mechanisms and molecules
  • 批准号:
    10043269
  • 项目类别:
  • 资助金额:
    $25.13万
  • 财政年份:
    2020
  • 负责人:
    Thomas David Manes
  • 依托单位:
Identification of human PECAM-1 receptor
  • 批准号:
    8352827
  • 项目类别:
  • 资助金额:
    $8.3万
  • 财政年份:
    2012
  • 负责人:
    Thomas David Manes
  • 依托单位:
海外基金